Haemonetics Corporation Amortization of Intangible Assets
Haemonetics Corporation (HAE) reported Amortization of Intangible Assets of $11.80 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- Haemonetics Corporation amortization of intangible assets for the quarter ending 2026-06-27 was $11.80M, a 11.28% decline year-over-year.
- Haemonetics Corporation amortization of intangible assets for the quarter ending 2026-03-28 was $12.00M, a 7.69% decline year-over-year.
- Haemonetics Corporation amortization of intangible assets for the quarter ending 2025-12-27 was $12.40M, a 10.79% decline year-over-year.
- Haemonetics Corporation amortization of intangible assets for the quarter ending 2025-09-27 was $12.80M, a 9.86% decline year-over-year.
- Haemonetics Corporation amortization of intangible assets for fiscal 2026 was $50.50M, a 9.17% decline from fiscal 2025.
- Haemonetics Corporation amortization of intangible assets for fiscal 2025 was $55.60M, a 34.30% increase from fiscal 2024.
- Haemonetics Corporation amortization of intangible assets for fiscal 2024 was $41.40M, a 1.66% decline from fiscal 2023.
- Haemonetics Corporation amortization of intangible assets for fiscal 2023 was $42.10M, a 25.62% decline from fiscal 2022.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | $11.80M 10-Q · filed 2026-08-06 | $23.80M derived: sum of 2 quarters · filed 2026-08-06 | $36.20M derived: sum of 3 quarters · filed 2026-08-06 | $49.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-28 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $24.40M derived: sum of 2 quarters · filed 2026-05-20 | $37.20M derived: sum of 3 quarters · filed 2026-05-20 | $50.50M 10-K · filed 2026-05-20 | ||||
| 2025-12-27 | $12.40M 10-Q · filed 2026-02-05 | $25.20M derived: sum of 2 quarters · filed 2026-02-05 | $38.50M 10-Q · filed 2026-02-05 | $51.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-09-27 | $12.80M 10-Q · filed 2025-11-06 | $26.10M 10-Q · filed 2025-11-06 | $39.10M derived: sum of 3 quarters · filed 2026-08-06 | $53.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-28 | $13.30M 10-Q · filed 2026-08-06 | $26.30M derived: sum of 2 quarters · filed 2026-08-06 | $40.20M derived: sum of 3 quarters · filed 2026-08-06 | $54.40M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-29 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $26.90M derived: sum of 2 quarters · filed 2026-05-20 | $41.10M derived: sum of 3 quarters · filed 2026-05-20 | $55.60M 10-K · filed 2026-05-20 | ||||
| 2024-12-28 | $13.90M 10-Q · filed 2026-02-05 | $28.10M derived: sum of 2 quarters · filed 2026-02-05 | $42.60M 10-Q · filed 2026-02-05 | $55.50M derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-09-28 | $14.20M 10-Q · filed 2025-11-06 | $28.70M 10-Q · filed 2025-11-06 | $41.60M derived: sum of 3 quarters · filed 2026-05-20 | $50.90M derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-06-29 | $14.50M 10-Q · filed 2025-08-07 | $27.40M derived: sum of 2 quarters · filed 2026-05-20 | $36.70M derived: sum of 3 quarters · filed 2026-05-20 | $46.10M derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-03-30 | $12.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $22.20M derived: sum of 2 quarters · filed 2026-05-20 | $31.60M derived: sum of 3 quarters · filed 2026-05-20 | $41.40M 10-K · filed 2026-05-20 | ||||
| 2023-12-30 | $9.30M 10-Q · filed 2025-02-06 | $18.70M derived: sum of 2 quarters · filed 2025-02-06 | $28.50M 10-Q · filed 2025-02-06 | $38.80M derived: sum of 4 quarters · filed 2025-05-21 | ||||
| 2023-09-30 | $9.40M 10-Q · filed 2024-11-07 | $19.20M 10-Q · filed 2024-11-07 | $29.50M derived: sum of 3 quarters · filed 2025-05-21 | $39.90M derived: sum of 4 quarters · filed 2025-05-21 | ||||
| 2023-07-01 | $9.70M 10-Q · filed 2024-08-08 | $20.10M derived: sum of 2 quarters · filed 2025-05-21 | $30.50M derived: sum of 3 quarters · filed 2025-05-21 | $41.10M derived: sum of 4 quarters · filed 2025-05-21 | ||||
| 2023-04-01 | $10.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-21 | $20.80M derived: sum of 2 quarters · filed 2025-05-21 | $31.40M derived: sum of 3 quarters · filed 2025-05-21 | $42.10M 10-K · filed 2025-05-21 | ||||
| 2022-12-31 | $10.40M 10-Q · filed 2024-02-08 | $8.08M 10-Q · filed 2023-02-07 | $21.00M derived: sum of 2 quarters · filed 2024-02-08 | $31.70M 10-Q · filed 2024-02-08 | $24.67M 10-Q · filed 2023-02-07 | $50.04M derived: sum of 4 quarters · filed 2024-05-20 | ||
| 2022-10-01 | $10.60M 10-Q · filed 2023-11-02 | $8.22M 10-Q · filed 2022-11-08 | $21.30M 10-Q · filed 2023-11-02 | $16.59M 10-Q · filed 2022-11-08 | $39.64M derived: sum of 3 quarters · filed 2024-05-20 | $51.79M derived: sum of 4 quarters · filed 2024-05-20 | ||
| 2022-07-02 | $8.37M 10-Q · filed 2022-08-10 | $29.04M derived: sum of 2 quarters · filed 2024-05-20 | $41.19M derived: sum of 3 quarters · filed 2024-05-20 | $52.59M derived: sum of 4 quarters · filed 2024-05-20 | ||||
| 2022-04-02 | $20.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-20 | $32.82M derived: sum of 2 quarters · filed 2024-05-20 | $44.22M derived: sum of 3 quarters · filed 2024-05-20 | $56.60M 10-K · filed 2024-05-20 | ||||
| 2022-01-01 | $12.15M 10-Q · filed 2023-02-07 | $23.55M derived: sum of 2 quarters · filed 2023-02-07 | $35.93M 10-Q · filed 2023-02-07 | $52.93M derived: sum of 4 quarters · filed 2023-05-22 | ||||
| 2021-10-02 | $11.40M 10-Q · filed 2022-11-08 | $23.78M 10-Q · filed 2022-11-08 | $40.77M derived: sum of 3 quarters · filed 2023-05-22 | $48.58M derived: sum of 4 quarters · filed 2023-05-22 | ||||
| 2021-07-03 | $12.38M 10-Q · filed 2022-08-10 | $29.38M derived: sum of 2 quarters · filed 2023-05-22 | $37.18M derived: sum of 3 quarters · filed 2023-05-22 | $45.31M derived: sum of 4 quarters · filed 2023-05-22 | ||||
| 2021-04-03 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-22 | $24.80M derived: sum of 2 quarters · filed 2023-05-22 | $32.93M derived: sum of 3 quarters · filed 2023-05-22 | $41.20M 10-K · filed 2023-05-22 | $32.83M 10-K · filed 2021-05-26 | |||
| 2020-12-26 | $7.80M 10-Q · filed 2022-02-08 | $15.93M derived: sum of 2 quarters · filed 2022-02-08 | $24.20M 10-Q · filed 2022-02-08 | |||||
| 2020-09-26 | $8.13M 10-Q · filed 2021-11-09 | $16.40M 10-Q · filed 2021-11-09 | ||||||
| 2020-06-27 | $8.26M 10-Q · filed 2021-08-11 | |||||||
| 2020-03-28 | $34.20M 10-K · filed 2022-05-25 | |||||||
| 2019-03-30 | $24.80M 10-K · filed 2021-05-26 | $32.60M 10-K · filed 2019-05-22 | ||||||
| 2018-03-31 | $31.90M 10-K · filed 2020-05-20 | |||||||
| 2017-04-01 | $37.20M 10-K · filed 2019-05-22 | |||||||
| 2016-04-02 | $33.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-23 | $59.30M 10-K · filed 2018-05-23 | ||||||
| 2015-12-26 | $25.90M 10-Q · filed 2016-02-02 | |||||||
| 2015-03-28 | $33.50M 10-K · filed 2017-05-24 | |||||||
| 2014-03-29 | $29.20M 10-K · filed 2016-06-01 | |||||||
| 2013-03-30 | $22.10M 10-K · filed 2015-05-22 | |||||||
| 2012-03-31 | $11.40M 10-K · filed 2014-05-22 | |||||||
| 2011-04-02 | $11.10M 10-K · filed 2013-05-20 | |||||||
| 2010-04-03 | $7.70M 10-K · filed 2012-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |